Department of Medicine, Queen Mary Hospital
Department of Medicine, Queen Mary Hospital
Hong Kong, Hong Kong5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial Prospective | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, coronary artery disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, myocardial ischemia, pulmonary hypertension, respiratory system disorder, vascular disorder | Not yet recruiting | Not stated | 2026-06-23 | NCT07663799 | |
| Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Phase 2 | 2025-06-11 | NCT06770842 | |
| Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder, heart valve disorder, pulmonary valve insufficiency | Recruiting | Phase 4 | 2025-05-20 | NCT06668389 | |
| Outcome of Allogeneic Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplant (HSCT) | Recruiting | Not stated | 2024-11-27 | NCT06702111 | |
| Asian Myeloproliferative Neoplasm (MPN) Registry | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, cellular phase chronic idiopathic myelofibrosis, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, myeloproliferative neoplasm, neoplasm, primary myelofibrosis, thrombocytosis disease | Recruiting | Not stated | 2023-05-31 | NCT05882773 |